Treatment Toxicity in Elderly Patients With Advanced Non–Small Cell Lung Cancer

医学 毒性 优势比 内科学 化疗 中性粒细胞减少症 置信区间 肺癌 阶段(地层学) 外科 古生物学 生物
作者
Minal Kale,Grace Mhango,Jorge Gómez,Keith Sigel,Cardinale B. Smith,Marcelo Bonomi,Juan P. Wisnivesky
出处
期刊:American Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:40 (5): 470-476 被引量:21
标识
DOI:10.1097/coc.0000000000000188
摘要

Objectives: Toxicity is a main concern limiting the use of chemotherapy and radiotherapy (RT) for elderly patients with non–small cell lung cancer (NSCLC). The objective of this study was to assess the rates of treatment-related toxicity among elderly stage IIIB and IV NSCLC patients. Materials and Methods: We used the Surveillance, Epidemiology, and End Results registry linked to Medicare records to identify 2596 stage IIIB and 14,803 stage IV NSCLC patients aged 70 years and above, diagnosed in 2000 or later. We compared rates of toxicity requiring hospitalization according to treatment (chemotherapy, RT, or chemoradiation [CRT]) in unadjusted and adjusted models controlling for selection bias using propensity scores. Results: Among stage IIIB patients, rates of any severe toxicity were 10.1%, 23.8%, 30.4%, and 39.2% for patients who received no treatment, RT, chemotherapy alone, and CRT, respectively. In stage IV patients, rates of any severe toxicity were 31.5% versus 13.5% among those treated with and without chemotherapy, respectively. In stage IIIB patients treated with CRT, the most common toxicities was esophagitis (odds ratio, 48.5; 95% confidence interval, 6.7-350.5). Among stage IV patients treated with chemotherapy, the risk of toxicity was highest for neutropenia (odds ratio, 8.4; 95% confidence interval, 6.1-11.5). Conclusions: Toxicity was relatively common among stage IIIB patients with up to a 6-fold increase in elderly individuals treated with CRT and a 4-fold increase in toxicities among stage IV patients. This information should be helpful to guide discussions about the risk-benefit ratio of chemotherapy and RT in elderly patients with advanced NSCLC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
背后海亦发布了新的文献求助10
刚刚
1秒前
zzz发布了新的文献求助10
1秒前
桐桐应助kyt采纳,获得10
1秒前
Akim应助糊涂的剑采纳,获得10
2秒前
鱼会淹死吗完成签到,获得积分10
2秒前
2秒前
tiam完成签到,获得积分20
2秒前
2秒前
orixero应助cloudy90采纳,获得10
3秒前
3秒前
3秒前
深时完成签到,获得积分10
4秒前
小马甲应助不不鱼采纳,获得50
4秒前
4秒前
4秒前
数学自动化完成签到,获得积分10
4秒前
梁嘉琦完成签到,获得积分10
4秒前
LJC发布了新的文献求助10
5秒前
汉堡包应助Lin采纳,获得10
5秒前
瘦瘦小萱发布了新的文献求助10
5秒前
5秒前
5秒前
Alvin发布了新的文献求助10
6秒前
脑洞疼应助顺心的惜蕊采纳,获得10
7秒前
jiuniangyuanzi完成签到,获得积分10
7秒前
lumen发布了新的文献求助10
7秒前
7秒前
8秒前
8秒前
简单发布了新的文献求助10
9秒前
萧水白应助王定伟采纳,获得10
9秒前
斯文明杰发布了新的文献求助10
9秒前
lmplzzp发布了新的文献求助10
9秒前
小吴完成签到,获得积分10
10秒前
阿拉蕾123完成签到,获得积分20
10秒前
songxuanyu完成签到,获得积分10
10秒前
小二郎应助YU采纳,获得10
10秒前
10秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3970172
求助须知:如何正确求助?哪些是违规求助? 3514982
关于积分的说明 11176568
捐赠科研通 3250212
什么是DOI,文献DOI怎么找? 1795198
邀请新用户注册赠送积分活动 875702
科研通“疑难数据库(出版商)”最低求助积分说明 805004